{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:12:33Z","timestamp":1791925953995,"version":"4.3.4"},"posted":{"date-parts":[[2023,7,29]]},"group-title":"Neuroscience","reference-count":180,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Appropriate interactions between antiretroviral therapies (ART) and drug transporters and metabolizing enzymes at the blood brain barrier (BBB) are critical to ensure adequate dosing of the brain to achieve HIV suppression. These proteins are modulated by demographic and lifestyle factors, including substance use. While understudied, illicit substances share drug transport and metabolism pathways with ART, increasing the potential for adverse drug:drug interactions. This is particularly important when considering the brain as it is relatively undertreated compared to peripheral organs and is vulnerable to substance use-mediated damage.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    We used an\n                    <jats:italic>in vitro<\/jats:italic>\n                    model of the human BBB to determine the extravasation of three first-line ART drugs, emtricitabine (FTC), tenofovir (TFV), and dolutegravir (DTG), in the presence and absence of cocaine, which served as our illicit substance model. The impact of cocaine on BBB integrity and permeability, drug transporters, metabolizing enzymes, and their master transcriptional regulators were evaluated to determine the mechanisms by which substance use impacted ART central nervous system (CNS) availability.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We determined that cocaine had a selective impact on ART extravasation, where it increased FTC\u2019s ability to cross the BBB while decreasing TFV. DTG concentrations that passed the BBB were below quantifiable limits. Interestingly, the potent neuroinflammatory modulator, lipopolysaccharide, had no effect on ART transport, suggesting a specificity for cocaine. Unexpectedly, cocaine did not breach the BBB, as permeability to albumin and tight junction proteins and adhesion molecules remained unchanged. Rather, cocaine selectively decreased the pregnane-x receptor (PXR), but not constitutive androstane receptor (CAR). Consequently, drug transporter expression and activity decreased in endothelial cells of the BBB, including p-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and multidrug resistance-associated protein 4 (MRP4). Further, cytochrome P450 3A4 (CYP3A4) enzymatic activity increased following cocaine treatment that coincided with decreased expression. Finally, cocaine modulated adenylate kinases are required to facilitate biotransformation of ART prodrugs to their phosphorylated, pharmacologically active counterparts.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings indicate that additional considerations are needed in CNS HIV treatment strategies for people who use cocaine, as it may limit ART efficacy through regulation of drug transport and metabolizing pathways at the BBB.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.07.28.551042","type":"posted-content","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T15:05:11Z","timestamp":1690643111000},"source":"Crossref","is-referenced-by-count":0,"title":["Cocaine Regulates Antiretroviral Therapy CNS Access Through Pregnane-X Receptor-Mediated Drug Transporter and Metabolizing Enzyme Modulation at the Blood Brain Barrier"],"prefix":"10.64898","author":[{"given":"Lisa B.","family":"Fridman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Knerler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira-Storm","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodnie Col\u00f3n","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca R.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0774-3750","authenticated-orcid":false,"given":"Benjamin C.","family":"Orsburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-2628","authenticated-orcid":false,"given":"Dionna W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2023080109102035000_2023.07.28.551042v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0085-4"},{"key":"2023080109102035000_2023.07.28.551042v1.2","first-page":"44","article-title":"A brief history of antiretroviral therapy of HIV infection: success and challenges","volume":"47","year":"2011","journal-title":"Ann. dell\u2019Ist. Super. di sanita"},{"key":"2023080109102035000_2023.07.28.551042v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00346-8"},{"key":"2023080109102035000_2023.07.28.551042v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.05.033"},{"key":"2023080109102035000_2023.07.28.551042v1.5","first-page":"894","article-title":"Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity","volume":"12","year":"2022","journal-title":"Biomol"},{"key":"2023080109102035000_2023.07.28.551042v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-015-0322-6"},{"key":"2023080109102035000_2023.07.28.551042v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135691"},{"key":"2023080109102035000_2023.07.28.551042v1.8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s13365-017-0573-5","article-title":"Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals","volume":"23","year":"2017","journal-title":"J Neurovirol"},{"key":"2023080109102035000_2023.07.28.551042v1.9","first-page":"867","article-title":"HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure","volume":"9","year":"2021","journal-title":"Nato Adv Sci Inst Se"},{"key":"2023080109102035000_2023.07.28.551042v1.10","doi-asserted-by":"publisher","DOI":"10.1172\/jci134815"},{"key":"2023080109102035000_2023.07.28.551042v1.11","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2020.0266"},{"key":"2023080109102035000_2023.07.28.551042v1.12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26456","article-title":"Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART","volume":"92","year":"2022","journal-title":"Ann. Neurol"},{"key":"2023080109102035000_2023.07.28.551042v1.13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26750"},{"key":"2023080109102035000_2023.07.28.551042v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.21"},{"key":"2023080109102035000_2023.07.28.551042v1.15","first-page":"1","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":"165","year":"2020","journal-title":"Adv. Drug Deliv. Rev"},{"key":"2023080109102035000_2023.07.28.551042v1.16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12248-020-00498-1","article-title":"HIV-1 Sanctuary Sites\u2014the Role of Membrane-Associated Drug Transporters and Drug Metabolic Enzymes","volume":"22","year":"2020","journal-title":"AAPS J"},{"key":"2023080109102035000_2023.07.28.551042v1.17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/QAD.0000000000002548","article-title":"Drug efflux transporters and metabolic enzymes in human circulating and testicular T-cell subsets: relevance to HIV pharmacotherapy","volume":"34","year":"2020","journal-title":"Aids"},{"key":"2023080109102035000_2023.07.28.551042v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.05.001"},{"key":"2023080109102035000_2023.07.28.551042v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.10.001"},{"key":"2023080109102035000_2023.07.28.551042v1.20","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.53"},{"key":"2023080109102035000_2023.07.28.551042v1.21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/1573409916666201006143007","article-title":"A Review on Pharmacokinetics Properties of Antiretroviral Drugs to Treat HIV-1 Infections","volume":"17","year":"2021","journal-title":"Curr. Comput.-Aided Drug Des"},{"key":"2023080109102035000_2023.07.28.551042v1.22","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328356e91c"},{"key":"2023080109102035000_2023.07.28.551042v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2014.01.014"},{"issue":"564","key":"2023080109102035000_2023.07.28.551042v1.24","first-page":"12","article-title":"Impact of Adenylate Kinases and Naturally Occurring Adenylate Kinase 2 Variants on the Phosphorylation of the Anti-HIV Drug Tenofovir","volume":"32","year":"2018","journal-title":"FASEB J"},{"key":"2023080109102035000_2023.07.28.551042v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(00)00048-6"},{"key":"2023080109102035000_2023.07.28.551042v1.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1907-1914.2005"},{"key":"2023080109102035000_2023.07.28.551042v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq447"},{"key":"2023080109102035000_2023.07.28.551042v1.28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/aid.2017.0243","article-title":"Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells","volume":"34","year":"2018","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2023080109102035000_2023.07.28.551042v1.29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpba.2017.08.028","article-title":"Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC\u2013MS\/MS method","volume":"146","year":"2017","journal-title":"J. Pharm. Biomed. Anal"},{"key":"2023080109102035000_2023.07.28.551042v1.30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/15257770903155899","article-title":"Nucleoside Diphosphate Kinase and the Activation of Antiviral Phosphonate Analogs of Nucleotides: Binding Mode and Phosphorylation of Tenofovir Derivatives","volume":"28","year":"2009","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"2023080109102035000_2023.07.28.551042v1.31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5501\/wjv.v4.i3.169","article-title":"Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics","volume":"4","year":"2015","journal-title":"World J. Virol"},{"key":"2023080109102035000_2023.07.28.551042v1.32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4103\/0971-5916.174549","article-title":"Individualization of antiretroviral therapy - Pharmacogenomic aspect","volume":"142","year":"2015","journal-title":"Indian J. M\u00e9d. Res"},{"key":"2023080109102035000_2023.07.28.551042v1.33","first-page":"1","article-title":"Pharmacogenomics of Antiretroviral Drug Metabolism and Transport","volume":"61","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"2023080109102035000_2023.07.28.551042v1.34","first-page":"1","article-title":"Individualization of antiretroviral therapy","volume":"5","year":"2011","journal-title":"Pharmacogenomics Pers. Med"},{"key":"2023080109102035000_2023.07.28.551042v1.35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.addr.2013.04.004","article-title":"Dynamical models of biomarkers and clinical progression for personalized medicine: The HIV context","volume":"65","year":"2013","journal-title":"Adv. Drug Deliv. Rev"},{"key":"2023080109102035000_2023.07.28.551042v1.36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.tim.2017.09.006","article-title":"Personalized Medicine and Infectious Disease Management","volume":"25","year":"2017","journal-title":"Trends Microbiol"},{"key":"2023080109102035000_2023.07.28.551042v1.37","first-page":"37","article-title":"Toward Personalized Medicine for HIV\/AIDS","volume":"3","year":"2021","journal-title":"J. AIDS HIV Treat"},{"key":"2023080109102035000_2023.07.28.551042v1.38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/COH.0000000000000608","article-title":"Polypharmacy in HIV: recent insights and future directions","volume":"15","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.idc.2019.04.006","article-title":"HIV and Substance Use Disorder Role of the HIV Physician","volume":"33","year":"2019","journal-title":"Infect. Dis. Clin. North Am"},{"key":"2023080109102035000_2023.07.28.551042v1.40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13722-018-0114-4","article-title":"Substance use and the HIV care continuum: important advances","volume":"13","year":"2018","journal-title":"Addict. Sci. Clin. Pr"},{"key":"2023080109102035000_2023.07.28.551042v1.41","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.48.10.1035"},{"key":"2023080109102035000_2023.07.28.551042v1.42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/19371918.2013.774665","article-title":"Substance Use Disorders and HIV\/AIDS Prevention and Treatment Intervention: Research and Practice Considerations","volume":"28","year":"2013","journal-title":"Soc. Work Public Heal"},{"key":"2023080109102035000_2023.07.28.551042v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2007.01.005"},{"key":"2023080109102035000_2023.07.28.551042v1.44","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1584-6"},{"key":"2023080109102035000_2023.07.28.551042v1.45","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s10461-016-1613-5","article-title":"The Impact of Comorbidities, Depression, and Substance Use Problems on Quality of Life Among Older Adults Living With HIV","volume":"21","year":"2017","journal-title":"AIDS Behav"},{"key":"2023080109102035000_2023.07.28.551042v1.46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/COH.0000000000000069","article-title":"Substance use in older HIV-infected patients","volume":"9","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.10.002"},{"key":"2023080109102035000_2023.07.28.551042v1.48","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-011-0093-5"},{"key":"2023080109102035000_2023.07.28.551042v1.49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/lgbt.2014.0020","article-title":"The Role of Substance Use and Mental Health Problems in Medication Adherence Among HIV-Infected MSM","volume":"1","year":"2014","journal-title":"LGBT Heal"},{"key":"2023080109102035000_2023.07.28.551042v1.50","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0319-6"},{"key":"2023080109102035000_2023.07.28.551042v1.51","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10461-017-1808-4","article-title":"The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States","volume":"22","year":"2018","journal-title":"AIDS Behav"},{"key":"2023080109102035000_2023.07.28.551042v1.52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.02.704","article-title":"Patterns of substance use among HIV-positive adults over 50: Implications for treatment and medication adherence","volume":"139","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"2023080109102035000_2023.07.28.551042v1.53","first-page":"75","article-title":"High prevalence of recreational and illicit drug use in German people living with HIV with a potential for drug\u2013drug interactions with antiretroviral therapy","volume":"32","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.09.016"},{"key":"2023080109102035000_2023.07.28.551042v1.55","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s40121-022-00694-w","article-title":"Do ART and Chemsex Drugs Get Along? Potential Drug\u2013Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study","volume":"11","year":"2022","journal-title":"Infect. Dis. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.56","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1540"},{"key":"2023080109102035000_2023.07.28.551042v1.57","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835584ea"},{"key":"2023080109102035000_2023.07.28.551042v1.58","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-008-0068-x"},{"key":"2023080109102035000_2023.07.28.551042v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60829-X"},{"key":"2023080109102035000_2023.07.28.551042v1.60","first-page":"936","article-title":"Associations of alcohol use","volume":"27","year":"2021","journal-title":"HIV infection, and age with brain white matter microstructure. J. NeuroVirology"},{"key":"2023080109102035000_2023.07.28.551042v1.61","first-page":"1724","article-title":"The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era","volume":"146426","year":"2019","journal-title":"Brain Res"},{"key":"2023080109102035000_2023.07.28.551042v1.62","first-page":"100","article-title":"Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition. Brain, Behav.","volume":"62","year":"2017","journal-title":"Immun"},{"key":"2023080109102035000_2023.07.28.551042v1.63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.pmbts.2019.04.001","article-title":"Is treated HIV infection still toxic to the brain?","volume":"165","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"2023080109102035000_2023.07.28.551042v1.64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e318229ba41","article-title":"Neurocognitive Impact of Substance Use in HIV Infection","volume":"58","year":"2011","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr"},{"key":"2023080109102035000_2023.07.28.551042v1.65","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/QAI.0000000000000258","article-title":"Mental, Neurological, and Substance Use Disorders in People Living With HIV\/AIDS in Low- and Middle-Income Countries","volume":"67","year":"2014","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr"},{"key":"2023080109102035000_2023.07.28.551042v1.66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fnins.2020.00513","article-title":"Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview","volume":"14","year":"2020","journal-title":"Front Neurosci-switz"},{"key":"2023080109102035000_2023.07.28.551042v1.67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01111"},{"key":"2023080109102035000_2023.07.28.551042v1.68","doi-asserted-by":"publisher","DOI":"10.1038\/nrd753"},{"key":"2023080109102035000_2023.07.28.551042v1.69","doi-asserted-by":"publisher","DOI":"10.1007\/BF02977789"},{"key":"2023080109102035000_2023.07.28.551042v1.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.08.006"},{"key":"2023080109102035000_2023.07.28.551042v1.71","first-page":"247296","article-title":"Establishing Transcriptional Signatures to Differentiate PXR-, CAR- and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes","volume":"365","year":"2018","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.030"},{"key":"2023080109102035000_2023.07.28.551042v1.73","doi-asserted-by":"crossref","unstructured":"Prakash, C. et al. Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions. Nucl. Recept. Res. 2, (2015).","DOI":"10.11131\/2015\/101178"},{"key":"2023080109102035000_2023.07.28.551042v1.74","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.754010"},{"key":"2023080109102035000_2023.07.28.551042v1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2013.01.025"},{"key":"2023080109102035000_2023.07.28.551042v1.76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07288.x"},{"key":"2023080109102035000_2023.07.28.551042v1.77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05720.x"},{"key":"2023080109102035000_2023.07.28.551042v1.78","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.063685"},{"key":"2023080109102035000_2023.07.28.551042v1.79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood\u2013brain barrier","volume":"97","year":"2015","journal-title":"Clin. Pharmacol. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.80","doi-asserted-by":"publisher","DOI":"10.2174\/138920011798357024"},{"key":"2023080109102035000_2023.07.28.551042v1.81","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.149690"},{"key":"2023080109102035000_2023.07.28.551042v1.82","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04432-w"},{"key":"2023080109102035000_2023.07.28.551042v1.83","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","year":"2019","journal-title":"Expert Opin Drug Met"},{"key":"2023080109102035000_2023.07.28.551042v1.84","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/17425255.2020.1814737","article-title":"An update on drug\u2013drug interactions between antiretroviral therapies and drugs of abuse in HIV systems","volume":"16","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"2023080109102035000_2023.07.28.551042v1.85","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3863-05.2006"},{"key":"2023080109102035000_2023.07.28.551042v1.86","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1212\/NXI.0000000000000036","article-title":"CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders","volume":"1","year":"2014","journal-title":"Neurology Neuroimmunol Neuroinflammation"},{"key":"2023080109102035000_2023.07.28.551042v1.87","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-2023(02)00359-6"},{"key":"2023080109102035000_2023.07.28.551042v1.88"},{"key":"2023080109102035000_2023.07.28.551042v1.89","first-page":"401","article-title":"JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals","volume":"97","year":"2014","journal-title":"J Leukocyte Biol"},{"key":"2023080109102035000_2023.07.28.551042v1.90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069270"},{"key":"2023080109102035000_2023.07.28.551042v1.91","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/cyto.a.22683","article-title":"Novel flow cytometric analysis of the blood-brain barrier","volume":"87","year":"2015","journal-title":"Cytom Part J Int Soc Anal Cytol"},{"key":"2023080109102035000_2023.07.28.551042v1.92","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/S2352-3018(20)30032-1","article-title":"Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1\/2 trial","volume":"7","year":"2020","journal-title":"Lancet HIV"},{"key":"2023080109102035000_2023.07.28.551042v1.93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/aid.2021.0115","article-title":"An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine\/Tenofovir Disoproxil Fumarate","volume":"38","year":"2022","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2023080109102035000_2023.07.28.551042v1.94","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31828f5088"},{"key":"2023080109102035000_2023.07.28.551042v1.95","unstructured":"(CVM), U. S. D. of H. and H. S., Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine. Bioanalytical Method Validation. Biopharmaceutics (2018)."},{"key":"2023080109102035000_2023.07.28.551042v1.96","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M113.037309"},{"key":"2023080109102035000_2023.07.28.551042v1.97","first-page":"1","article-title":"Antiretroviral Concentrations and Surrogate Measures of Efficacy in the Brain Tissue and CSF of Preclinical Species","volume":"49","year":"2019","journal-title":"Xenobiotica"},{"key":"2023080109102035000_2023.07.28.551042v1.98","doi-asserted-by":"crossref","unstructured":"Ferrara, M. et al. Antiretroviral drug concentrations in brain tissue of adult decedents. Aids Lond Engl Publish Ahead of Print , (2020).","DOI":"10.1097\/QAD.0000000000002628"},{"key":"2023080109102035000_2023.07.28.551042v1.99","doi-asserted-by":"crossref","unstructured":"Devanathan, A. S. , et al. Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs. Antimicrob Agents Ch 64, (2019).","DOI":"10.1128\/AAC.01639-19"},{"key":"2023080109102035000_2023.07.28.551042v1.100","doi-asserted-by":"crossref","first-page":"134475","DOI":"10.1016\/j.neulet.2019.134475","article-title":"Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia","volume":"712","year":"2019","journal-title":"Neurosci Lett"},{"key":"2023080109102035000_2023.07.28.551042v1.101","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS Neurotoxicity of Antiretrovirals","volume":"16","year":"2021","journal-title":"J Neuroimmune Pharm"},{"key":"2023080109102035000_2023.07.28.551042v1.102","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.086744"},{"key":"2023080109102035000_2023.07.28.551042v1.103","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/QAD.0000000000002925","article-title":"FDG PET\/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients","volume":"35","year":"2021","journal-title":"Aids"},{"key":"2023080109102035000_2023.07.28.551042v1.104","doi-asserted-by":"crossref","first-page":"198523","DOI":"10.1016\/j.virusres.2021.198523","article-title":"HIV-1 PERSISTENCE IN THE CNS: MECHANISMS OF LATENCY, PATHOGENESIS AND AN UPDATE ON ERADICATION STRATEGIES","volume":"303","year":"2021","journal-title":"Virus Res"},{"key":"2023080109102035000_2023.07.28.551042v1.105","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab228"},{"key":"2023080109102035000_2023.07.28.551042v1.106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cts.12620","article-title":"Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive Impairment","volume":"12","year":"2019","journal-title":"Clin Transl Sci"},{"key":"2023080109102035000_2023.07.28.551042v1.107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.aca.2019.01.015","article-title":"Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"1056","year":"2019","journal-title":"Anal Chim Acta"},{"key":"2023080109102035000_2023.07.28.551042v1.108","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The Paradox of HIV Blood\u2013Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies","volume":"43","year":"2020","journal-title":"Trends Neurosci"},{"key":"2023080109102035000_2023.07.28.551042v1.109","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0811394"},{"key":"2023080109102035000_2023.07.28.551042v1.110","doi-asserted-by":"crossref","first-page":"768108","DOI":"10.3389\/fcimb.2021.768108","article-title":"Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy","volume":"11","year":"2021","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"2023080109102035000_2023.07.28.551042v1.111","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-008-9322-x"},{"key":"2023080109102035000_2023.07.28.551042v1.112","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)03247-9"},{"key":"2023080109102035000_2023.07.28.551042v1.113","first-page":"507","article-title":"Lipopolysaccharide alters the blood\u2013brain barrier transport of amyloid \u03b2 protein: A mechanism for inflammation in the progression of Alzheimer\u2019s disease. Brain, Behav.","volume":"23","year":"2009","journal-title":"Immun"},{"key":"2023080109102035000_2023.07.28.551042v1.114","unstructured":"Barton, S. M. et al. Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model. J. Alzheimer\u2019s Dis. Preprint , 1\u201311 (2018)."},{"key":"2023080109102035000_2023.07.28.551042v1.115","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-009-9446-7"},{"key":"2023080109102035000_2023.07.28.551042v1.116","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0434-1"},{"key":"2023080109102035000_2023.07.28.551042v1.117","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-2862(02)00009-2"},{"key":"2023080109102035000_2023.07.28.551042v1.118","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.017954"},{"key":"2023080109102035000_2023.07.28.551042v1.119","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00292-13"},{"key":"2023080109102035000_2023.07.28.551042v1.120","first-page":"955","article-title":"Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms","volume":"30","year":"2008","journal-title":"Xenobiotica"},{"key":"2023080109102035000_2023.07.28.551042v1.121","first-page":"83","article-title":"Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450","volume":"851","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"2023080109102035000_2023.07.28.551042v1.122","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/ptr.5942","article-title":"PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids","volume":"31","year":"2017","journal-title":"Phytother Res"},{"key":"2023080109102035000_2023.07.28.551042v1.123","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.542"},{"key":"2023080109102035000_2023.07.28.551042v1.124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/088922204323087723","article-title":"Prevention of AIDS Dementia by HAART Does Not Depend on Cerebrospinal Fluid Drug Penetrance","volume":"20","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2023080109102035000_2023.07.28.551042v1.125","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.31"},{"key":"2023080109102035000_2023.07.28.551042v1.126","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10735-019-09852-w","article-title":"Investigating time dependent brain distribution of nevirapine via mass spectrometric imaging","volume":"50","year":"2019","journal-title":"J. Mol. Histol"},{"key":"2023080109102035000_2023.07.28.551042v1.127","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8510"},{"key":"2023080109102035000_2023.07.28.551042v1.128","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acsptsci.0c00015","article-title":"Spatial Distribution Profiles of Emtricitabine, Tenofovir, Efavirenz, and Rilpivirine in Murine Tissues Following In Vivo Dosing Correlate with Their Safety Profiles in Humans","volume":"3","year":"2020","journal-title":". ACS Pharmacol. Transl. Sci"},{"key":"2023080109102035000_2023.07.28.551042v1.129","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.2.361"},{"key":"2023080109102035000_2023.07.28.551042v1.130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/QAD.0000000000002291","article-title":"Double dissociation of HIV and substance use disorder effects on neurocognitive tasks dependent on striatal integrity","volume":"33","year":"2019","journal-title":"AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.131","first-page":"247","article-title":"Focus on the brain: HIV infection and alcoholism: comorbidity effects on brain structure and function","volume":"33","year":"2010","journal-title":"Alcohol Res. Heal.L: J. Natl. Inst. Alcohol Abus. Alcohol"},{"key":"2023080109102035000_2023.07.28.551042v1.132","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11481-020-09957-0","article-title":"Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior","volume":"15","year":"2020","journal-title":"J. Neuroimmune Pharmacol"},{"key":"2023080109102035000_2023.07.28.551042v1.133","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s13365-022-01102-2","article-title":"Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV","volume":"29","year":"2023","journal-title":"J. NeuroVirology"},{"key":"2023080109102035000_2023.07.28.551042v1.134","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-012-0141-y"},{"key":"2023080109102035000_2023.07.28.551042v1.135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuro.2022.03.009","article-title":"Blood brain barrier as an interface for alcohol induced neurotoxicity during development","volume":"90","year":"2022","journal-title":"NeuroToxicology"},{"key":"2023080109102035000_2023.07.28.551042v1.136","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1523\/JNEUROSCI.5618-10.2011","article-title":"Cocaine hijacks \u03c31 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS","volume":"31","year":"2011","journal-title":"J Neurosci Official J Soc Neurosci"},{"key":"2023080109102035000_2023.07.28.551042v1.137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pbb.2018.05.005","article-title":"Cocaine impairs serial-feature negative learning and blood-brain barrier integrity","volume":"170","year":"2018","journal-title":"Pharmacol. Biochem. Behav"},{"key":"2023080109102035000_2023.07.28.551042v1.138","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11481-007-9091-1","article-title":"Cocaine-mediated Alteration in Tight Junction Protein Expression and Modulation of CCL2\/CCR2 Axis Across the Blood-Brain Barrier: Implications for HIV-Dementia","volume":"3","year":"2008","journal-title":"J Neuroimmune Pharm"},{"key":"2023080109102035000_2023.07.28.551042v1.139","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11481-017-9726-9","article-title":"Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis","volume":"12","year":"2017","journal-title":"J Neuroimmune Pharm"},{"key":"2023080109102035000_2023.07.28.551042v1.140","first-page":"539","article-title":"Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress","volume":"36","year":"2015","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"2023080109102035000_2023.07.28.551042v1.141","doi-asserted-by":"crossref","unstructured":"Patel, S. et al. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro. Antimicrob. Agents Chemother. 61, (2017).","DOI":"10.1128\/AAC.01307-17"},{"key":"2023080109102035000_2023.07.28.551042v1.142","doi-asserted-by":"crossref","first-page":"151271","DOI":"10.1016\/j.ejcb.2022.151271","article-title":"HIV-1 gp120 and tobacco smoke synergistically disrupt the integrity of the blood-brain barrier","volume":"101","year":"2022","journal-title":"Eur. J. Cell Biol"},{"key":"2023080109102035000_2023.07.28.551042v1.143","doi-asserted-by":"crossref","first-page":"984375","DOI":"10.3389\/fcell.2022.984375","article-title":"Morphine-mediated release of astrocyte-derived extracellular vesicle miR-23a induces loss of pericyte coverage at the blood-brain barrier: Implications for neuroinflammation","volume":"10","year":"2022","journal-title":"Front. Cell Dev. Biol"},{"key":"2023080109102035000_2023.07.28.551042v1.144","doi-asserted-by":"crossref","first-page":"114478","DOI":"10.1016\/j.biopha.2023.114478","article-title":"Overview of blood-brain barrier dysfunction in methamphetamine abuse","volume":"161","year":"2023","journal-title":"Biomed. Pharmacother"},{"key":"2023080109102035000_2023.07.28.551042v1.145","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/v13091883","article-title":"Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders","volume":"13","year":"2021","journal-title":"Viruses"},{"key":"2023080109102035000_2023.07.28.551042v1.146","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00121"},{"key":"2023080109102035000_2023.07.28.551042v1.147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31065-5"},{"key":"2023080109102035000_2023.07.28.551042v1.148","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1917"},{"key":"2023080109102035000_2023.07.28.551042v1.149","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5011"},{"key":"2023080109102035000_2023.07.28.551042v1.150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0000000000000207","article-title":"Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women","volume":"11","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.151","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-00230-3"},{"key":"2023080109102035000_2023.07.28.551042v1.152","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","year":"2012","journal-title":"J Cereb Blood Flow Metabolism Official J Int Soc Cereb Blood Flow Metabolism"},{"key":"2023080109102035000_2023.07.28.551042v1.153","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70326-5"},{"key":"2023080109102035000_2023.07.28.551042v1.154","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.1.3"},{"key":"2023080109102035000_2023.07.28.551042v1.155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","year":"2023","journal-title":"Signal Transduct. Target. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.156","doi-asserted-by":"publisher","DOI":"10.1021\/jm00084a001"},{"key":"2023080109102035000_2023.07.28.551042v1.157","doi-asserted-by":"publisher","DOI":"10.1126\/science.2820058"},{"key":"2023080109102035000_2023.07.28.551042v1.158","doi-asserted-by":"publisher","DOI":"10.1038\/386827a0"},{"key":"2023080109102035000_2023.07.28.551042v1.159","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2146"},{"key":"2023080109102035000_2023.07.28.551042v1.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.05.058"},{"key":"2023080109102035000_2023.07.28.551042v1.161","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3"},{"key":"2023080109102035000_2023.07.28.551042v1.162","first-page":"951","article-title":"Regulation of the human norepinephrine transporter by cocaine and amphetamine","volume":"295","year":"2000","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.6.2542"},{"key":"2023080109102035000_2023.07.28.551042v1.164","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90132-B"},{"key":"2023080109102035000_2023.07.28.551042v1.165","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7699"},{"key":"2023080109102035000_2023.07.28.551042v1.166","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.091039298"},{"key":"2023080109102035000_2023.07.28.551042v1.167","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1316.006"},{"key":"2023080109102035000_2023.07.28.551042v1.168","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.45.28321"},{"key":"2023080109102035000_2023.07.28.551042v1.169","first-page":"97","article-title":"Cocaine-induced structural and functional impairments of the glymphatic pathway in mice. Brain, Behav.","volume":"88","year":"2020","journal-title":"Immun"},{"key":"2023080109102035000_2023.07.28.551042v1.170","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02064-5"},{"key":"2023080109102035000_2023.07.28.551042v1.171","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41598-021-81148-0","article-title":"Electronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells","volume":"11","year":"2021","journal-title":"Sci. Rep"},{"key":"2023080109102035000_2023.07.28.551042v1.172","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2010.10.014","article-title":"Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir","volume":"402","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2023080109102035000_2023.07.28.551042v1.173","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01330.x"},{"key":"2023080109102035000_2023.07.28.551042v1.174","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1248\/bpb.b18-00134","article-title":"Impact of Nicotine Transport across the Blood\u2013Brain Barrier: Carrier-Mediated Transport of Nicotine and Interaction with Central Nervous System Drugs","volume":"41","year":"2018","journal-title":"Biol. Pharm. Bull"},{"key":"2023080109102035000_2023.07.28.551042v1.175","first-page":"21","article-title":"Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers","volume":"261","year":"1992","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.176","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170504095823"},{"key":"2023080109102035000_2023.07.28.551042v1.177","first-page":"19","article-title":"Substance use Patterns and HIV-1 RNA Viral Load Rebound among HIV-Positive Illicit Drug users in a Canadian Setting","volume":"24","year":"2018","journal-title":"Antivir. Ther"},{"key":"2023080109102035000_2023.07.28.551042v1.178","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/QAD.0000000000002551","article-title":"Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs","volume":"34","year":"2020","journal-title":"AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.179","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0000000000003234","article-title":"Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs","volume":"36","year":"2022","journal-title":"AIDS"},{"key":"2023080109102035000_2023.07.28.551042v1.180","first-page":"D1539","article-title":"The ProteomeXchange consortium at 10 years: 2023 update","volume":"51","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.07.28.551042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:00:03Z","timestamp":1768453203000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.07.28.551042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":180,"URL":"https:\/\/doi.org\/10.1101\/2023.07.28.551042","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12987-023-00507-3","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,7,29]]},"subtype":"preprint"}}